Staph A cells, which are fixed cells with a high density of protein A on their surface, are commonly used in ChIP assays.
Like protein A and G affinity resins, they can bind antibodies associated with chromatin complexes prior to washing and eluting pure proteinDNA complexes.
These cells exhibit a high binding capacity of antibodies (≥2 mg human IgG per 100 mg of cells) relative to other technologies (protein A magnetic beads, for example, bind ~0.8 mg per 100 mg of beads).
Because of their high capacity, Staph A cells deliver very high sensitivity ChIP assays. Due to the possibility of aspirating cells after the equilibration, capture and wash steps, a disadvantage for Staph A cells is the difficulty in processing multiple ChIP samples in parallel with a multichannel pipette.
For this reason, each sample must be processed individually, adding significant time to the overall protocol and potentially reducing reproducibility of the technology.